重大信息--Sorrento Therapeutics (SRNE) shares as much as doubled as the biopharma company said it was zeroing in on a potential breakthrough drug to treat the coronavirus. The San Diego biopharma said in a statement that in laboratory research, a new treatment provides "100% inhibition" of SARS-CoV-2.
CEO Henry Ji 是個中國人。今天此股大漲,翻1.5倍,因為CEO說了這句話。如果是真的,拿是不是買航空遊輪股的好時機?
As of 5/15/2020, NCLH: $11.11; CCL: $12.97; DAL: $19.41; LUV: $24.14;